170 related articles for article (PubMed ID: 16472548)
1. Response of steroid-treated former preterm infants to a single dose of meningococcal C conjugate vaccine.
Clarke P; Robinson MJ; Ahmad I; Bedford-Russell AR; Connell JE; Powell PJ; Heath PT
Vaccine; 2006 Apr; 24(16):3273-8. PubMed ID: 16472548
[TBL] [Abstract][Full Text] [Related]
2. Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines.
Slack MH; Schapira D; Thwaites RJ; Burrage M; Southern J; Andrews N; Borrow R; Goldblatt D; Miller E
J Infect Dis; 2001 Dec; 184(12):1617-20. PubMed ID: 11740740
[TBL] [Abstract][Full Text] [Related]
3. DT5aP-Hib-IPV and MCC vaccines: preterm infants' response to accelerated immunisation.
Slack MH; Cade S; Schapira D; Thwaites RJ; Crowley-Luke A; Southern J; Borrow R; Miller E
Arch Dis Child; 2005 Apr; 90(4):338-41. PubMed ID: 15781918
[TBL] [Abstract][Full Text] [Related]
4. Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children.
Borrow R; Goldblatt D; Andrews N; Richmond P; Southern J; Miller E
J Infect Dis; 2001 Aug; 184(3):377-80. PubMed ID: 11443568
[TBL] [Abstract][Full Text] [Related]
5. Passive protection in the infant rat protection assay by sera taken before and after vaccination of teenagers with serogroup B meningococcal outer membrane vesicle vaccines.
Toropainen M; Saarinen L; Wedege E; Bolstad K; Mäkelä PH; Käyhty H
Vaccine; 2005 Sep; 23(40):4821-33. PubMed ID: 15970361
[TBL] [Abstract][Full Text] [Related]
6. Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults.
Southern J; Deane S; Ashton L; Borrow R; Goldblatt D; Andrews N; Balmer P; Morris R; Kroll JS; Miller E
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1100-4. PubMed ID: 15539513
[TBL] [Abstract][Full Text] [Related]
7. Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory.
Richmond P; Borrow R; Miller E; Clark S; Sadler F; Fox A; Begg N; Morris R; Cartwright K
J Infect Dis; 1999 Jun; 179(6):1569-72. PubMed ID: 10228085
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
Perrett KP; Snape MD; Ford KJ; John TM; Yu LM; Langley JM; McNeil S; Dull PM; Ceddia F; Anemona A; Halperin SA; Dobson S; Pollard AJ
Pediatr Infect Dis J; 2009 Mar; 28(3):186-93. PubMed ID: 19209097
[TBL] [Abstract][Full Text] [Related]
9. Immune memory in children previously vaccinated with an experimental quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine.
Pichichero M; Papa T; Blatter M; Mitchell D; Kratz R; Sneed J; Bassily E; Casey J; Gilmet G
Pediatr Infect Dis J; 2006 Nov; 25(11):995-1000. PubMed ID: 17072120
[TBL] [Abstract][Full Text] [Related]
10. Investigation of serum bactericidal activity in childhood and adolescence 3-6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine.
Sakou II; Tzanakaki G; Tsolia MN; Sioumala M; Barbouni A; Kyprianou M; Papaevangelou V; Tsitsika A; Blackwell CC; Kafetzis D; Kremastinou J
Vaccine; 2009 Jul; 27(33):4408-11. PubMed ID: 19500554
[TBL] [Abstract][Full Text] [Related]
11. Antibody persistence following MeNZB vaccination of adults and children and response to a fourth dose in toddlers.
Jackson C; Lennon D; Wong S; Yan J; Stewart J; Reid S; Oster P; Ypma E; Martin D
Arch Dis Child; 2011 Aug; 96(8):744-51. PubMed ID: 21596727
[TBL] [Abstract][Full Text] [Related]
12. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
14. Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies.
Rezaei N; Aghamohammadi A; Siadat SD; Nejati M; Ahmadi H; Moin M; Pourpak Z; Kamali S; Norouzian D; Tabaraei B; Read RC
Vaccine; 2007 Jul; 25(29):5308-14. PubMed ID: 17574314
[TBL] [Abstract][Full Text] [Related]
15. Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals.
Balmer P; Falconer M; McDonald P; Andrews N; Fuller E; Riley C; Kaczmarski E; Borrow R
Infect Immun; 2004 Jan; 72(1):332-7. PubMed ID: 14688112
[TBL] [Abstract][Full Text] [Related]
16. Is a single infant priming dose of meningococcal serogroup C conjugate vaccine in the United Kingdom sufficient?
Findlow H; Borrow R
Hum Vaccin Immunother; 2015; 11(6):1501-6. PubMed ID: 25912095
[TBL] [Abstract][Full Text] [Related]
17. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of meningococcal serogroup C conjugate vaccine programs in Canadian children: interim analysis.
Bettinger JA; Scheifele DW; Halperin SA; Kellner JD; Vanderkooi OG; Schryvers A; De Serres G; Alcantara J
Vaccine; 2012 Jun; 30(27):4023-7. PubMed ID: 22537988
[TBL] [Abstract][Full Text] [Related]
19. Natural and vaccine-induced immunity to Neisseria meningitidis serogroup C in asplenic patients with β-thalassemia.
Spoulou V; Tzanakaki G; Lekka S; Chouliaras G; Ladis V; Theodoridou M
Vaccine; 2011 Jun; 29(27):4435-8. PubMed ID: 21497638
[TBL] [Abstract][Full Text] [Related]
20. Immunologic memory with no detectable bactericidal antibody response to a first dose of meningococcal serogroup C conjugate vaccine at four years.
McVernon J; MacLennan J; Pollard AJ; Oster P; Wakefield MJ; Danzig L; Moxon ER
Pediatr Infect Dis J; 2003 Jul; 22(7):659-61. PubMed ID: 12886896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]